Debbi EM, Agar G, Fichman G, Ziv YB, Kardosh R, Halperin N, et al
The presence of DSIP-LI in several HPLC fractions from conditioned culture media indicates secretion of DSIP-LI from cultured pheochromocytoma cells
This interaction is thought to activate key biological pathways involved in wound healing, collagen synthesis, hair growth, immune function, and angiogenesis (the formation of new blood vessels)
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
d- and l- where relevant, are prohibited
Virulence 10, 315333